AltStreet
EDGAR Verified
Primary Source · SEC.gov

CCA Longevity Fund III (US), LLC

CIK 0001814495Fund Vehicle2023 vintage506(b), 3(c)

Raised

$55M

Investors

51

Min Invest

$250,000

AltStreet Analysis

·

Generated from EDGAR primary sources

CCA Longevity Fund III (US), LLC is a Delaware-domiciled pooled investment fund targeting longevity biotech investments. This amended Form D reports $54.6M raised from 51 investors under Rule 506(b) and 3(c) exemptions, with a $250K minimum investment. William Corry is listed as director.

This longevity biotech fund employs a standard 506(b) private placement structure with a $250K minimum, positioning it in the middle tier of access relative to the asset class. The 51-investor count approaches the Section 3(c)(1) ceiling of 100 beneficial owners, typical for funds electing this exemption route rather than 3(c)(7).

Data Flags

investor_count51 investors contributing $54.6M yields an average check size of approximately $1.07M, notably low for a $250K minimum fund—suggests concentration in or near the minimum threshold
generalAmendment filing with no first sale date disclosed; while common for ongoing fundraises, the $54.6M raise is below the institutional threshold where omission is routine

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001814495
Entity NameCCA Longevity Fund III (US), LLC
Exemption506(b), 3(c)
First Sale Date—
Filing DateMarch 1, 2023
Accession Number0001814495-23-000002
Total Amount Sold$55M
Total Investors51
Minimum Investment$250,000
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

William Corry

Director · Vero Beach, FL

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.